Literature DB >> 10792288

Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction.

K M Ardeshna1, A R Pizzey, N S Thomas, S Orr, D C Linch, S Devereux.   

Abstract

Dendritic cells may be generated ex vivo from CD34+ progenitor cells or peripheral blood mononuclear cells. Initial reports suggested that monocyte-derived dendritic cells (MoDCs) arise from a proliferating precursor and several groups subsequently reported successful retroviral transduction of these cells, again implying that cell division occurs. As this is of importance in the development of immunotherapy protocols, we investigated whether monocytes proliferate as they differentiate into MoDCs and also their susceptibility to retroviral transduction. During MoDC differentiation, there was a 51 +/- 12% reduction in cell number, 98% of cells were in G0/G1, no DNA synthesis was detectable and the cell cycle regulatory proteins pRb and p130 were in the hypophosphorylated forms observed in non-cycling cells. As expected from these results, MoDCs were refractory to transduction with a GALV1 pseudotyped Moloney murine leukaemia virus (MoMLV)-based retroviral vector. In contrast, generation of DCs from purified CD34 progenitors was accompanied by rapid entry into the cell cycle and a 41.1-fold cell expansion at the end of 14 d culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792288     DOI: 10.1046/j.1365-2141.2000.01956.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells.

Authors:  J-M Humbert; C Frecha; F Amirache Bouafia; T H N'Guyen; S Boni; F-L Cosset; E Verhoeyen; F Halary
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  Efficient Culture of Human Naive and Memory B Cells for Use as APCs.

Authors:  Kuei-Ying Su; Akiko Watanabe; Chen-Hao Yeh; Garnett Kelsoe; Masayuki Kuraoka
Journal:  J Immunol       Date:  2016-10-10       Impact factor: 5.422

3.  Characterization of Human Monocyte-derived Dendritic Cells by Imaging Flow Cytometry: A Comparison between Two Monocyte Isolation Protocols.

Authors:  Gloria Figueroa; Tiyash Parira; Alejandra Laverde; Gianna Casteleiro; Amal El-Mabhouh; Madhavan Nair; Marisela Agudelo
Journal:  J Vis Exp       Date:  2016-10-18       Impact factor: 1.355

4.  Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.

Authors:  F Zhu; G Ramadan; B Davies; D A Margolis; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

5.  Bacterial infection remodels the DNA methylation landscape of human dendritic cells.

Authors:  Alain Pacis; Ludovic Tailleux; Alexander M Morin; John Lambourne; Julia L MacIsaac; Vania Yotova; Anne Dumaine; Anne Danckaert; Francesca Luca; Jean-Christophe Grenier; Kasper D Hansen; Brigitte Gicquel; Miao Yu; Athma Pai; Chuan He; Jenny Tung; Tomi Pastinen; Michael S Kobor; Roger Pique-Regi; Yoav Gilad; Luis B Barreiro
Journal:  Genome Res       Date:  2015-09-21       Impact factor: 9.043

6.  Efficient generation of antigen-specific CTLs by the BAFF-activated human B Lymphocytes as APCs: a novel approach for immunotherapy.

Authors:  Zhang Yiwen; Gao Shilin; Chen Yingshi; Su Lishi; Luo Baohong; Liu Chao; Li Linghua; Pan Ting; Zhang Hui
Journal:  Oncotarget       Date:  2016-11-22

7.  The N-Terminal Domain of cGAS Determines Preferential Association with Centromeric DNA and Innate Immune Activation in the Nucleus.

Authors:  Matteo Gentili; Xavier Lahaye; Francesca Nadalin; Guilherme P F Nader; Emilia Puig Lombardi; Solène Herve; Nilushi S De Silva; Derek C Rookhuizen; Elina Zueva; Christel Goudot; Mathieu Maurin; Aurore Bochnakian; Sebastian Amigorena; Matthieu Piel; Daniele Fachinetti; Arturo Londoño-Vallejo; Nicolas Manel
Journal:  Cell Rep       Date:  2019-02-26       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.